![N-[[2-(5-nitrothiophen-2-yl)-1,3-thiazol-4-yl]methylideneamino]morpholine-4-carboxamide结构式](https://www.chemsrc.com/caspic/156/56527-69-6.png)
N-[[2-(5-nitrothiophen-2-yl)-1,3-thiazol-4-yl]methylideneamino]morpholine-4-carboxamide结构式
|
常用名 | N-[[2-(5-nitrothiophen-2-yl)-1,3-thiazol-4-yl]methylideneamino]morpholine-4-carboxamide | 英文名 | N-[[2-(5-nitrothiophen-2-yl)-1,3-thiazol-4-yl]methylideneamino]morpholine-4-carboxamide |
|---|---|---|---|---|
| CAS号 | 56527-69-6 | 分子量 | 367.40300 | |
| 密度 | 1.67g/cm3 | 沸点 | N/A | |
| 分子式 | C13H13N5O4S2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-[[2-(5-nitrothiophen-2-yl)-1,3-thiazol-4-yl]methylideneamino]morpholine-4-carboxamide |
|---|
| 密度 | 1.67g/cm3 |
|---|---|
| 分子式 | C13H13N5O4S2 |
| 分子量 | 367.40300 |
| 精确质量 | 367.04100 |
| PSA | 172.61000 |
| LogP | 2.82100 |
|
~%
N-[[2-(5-nitrot... 56527-69-6 |
| 文献：Verge; Roffey Journal of Medicinal Chemistry, 1975 , vol. 18, # 8 p. 794 - 797 |
|
~%
N-[[2-(5-nitrot... 56527-69-6 |
| 文献：Verge; Roffey Journal of Medicinal Chemistry, 1975 , vol. 18, # 8 p. 794 - 797 |
|
~%
N-[[2-(5-nitrot... 56527-69-6 |
| 文献：Verge; Roffey Journal of Medicinal Chemistry, 1975 , vol. 18, # 8 p. 794 - 797 |
|
~%
N-[[2-(5-nitrot... 56527-69-6 |
| 文献：Verge; Roffey Journal of Medicinal Chemistry, 1975 , vol. 18, # 8 p. 794 - 797 |
|
~%
N-[[2-(5-nitrot... 56527-69-6 |
| 文献：Verge; Roffey Journal of Medicinal Chemistry, 1975 , vol. 18, # 8 p. 794 - 797 |
|
~%
N-[[2-(5-nitrot... 56527-69-6 |
| 文献：Verge; Roffey Journal of Medicinal Chemistry, 1975 , vol. 18, # 8 p. 794 - 797 |
![N,N-dimethyl-N'-[2-(5-nitro-thiophen-2-yl)-thiazol-4-ylmethylene]-benzene-1,4-diamine N'-oxide结构式](https://www.chemsrc.com/caspic/171/31898-36-9.png)
![1-[2-(5-nitro-thiophen-2-yl)-thiazol-4-ylmethyl]-pyridinium, chloride结构式](https://www.chemsrc.com/caspic/285/31898-33-6.png)
![1-[2-(5-nitro-thiophen-2-yl)-thiazol-4-ylmethyl]-1,3,5,7-tetraaza-adamantanium, chloride结构式](https://www.chemsrc.com/caspic/323/31898-32-5.png)
